Atrium Therapeutics, Inc.

RNA·NasdaqGS
Compare
8.21−0.19 (−2.26%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close8.40
Open8.40
Day range8.218.48
52-week range7.6316.77
Off day high−3.20%
Off 52-week high−51.04%
Volume87.24K
Avg. volume (3M)257.61K
Market cap140.44M
EPS (TTM)-5.44
Forward P/E-1.02
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding17.11M
Short interest—
Earnings dateNov 9, 2026 (est.)
Analyst target—
Profit margin—

Against its peers

Compare in full ›
RNA TNYA SLDB RCKT PRQR LXEO
Market cap 140.44M 126.80M 719.48M 272.24M 228.61M 249.55M
P/E (TTM) — — — — — —
Forward P/E -1.0 -1.4 -3.9 -1.9 -3.4 -2.2
Price/book 0.7 1.8 1.9 0.7 2.6 1.0
Dividend yield — — — — — —
1-year change −43.05% −70.71% +14.31% −26.22% −28.82% −60.61%
Today −2.26% −2.55% −2.33% −3.13% −0.61% −5.88%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All RNA news ›

No recent coverage in the 4Search index.

From articles in the 4Search news index.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.